Gastrofish for Colon Cancer
December 28, 2009 | Terry Sharrer
Gastrocor, Inc. (Glen Allen, VA) has developed the first tissue-based fluorescence in situ hybridization (FISH) diagnostic test for chromosome abnormalities in adenocarcinomas of the colon as collected from GI tract biopsies. Apparently this is now in use at Bostwick Laboratories-a pathology reference lab in Richmond, VA. MORE